REGENXBIO Inc.RGNXNASDAQ

Revenue (LTM)

$170M

+104.5% YoY

Net Income (LTM)

$-194M

+14.6% YoY

Free Cash Flow

$-126M

Revenue CAGR (5Y)

-22.4%

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	470	113↓76.0%	90↓19.9%	83↓7.7%	170↑104.5%
Gross Profit	419	58↓86.1%	53↓8.9%	50↓6.2%	150↑201.7%
Operating Income	160	-263↓264.3%	-268↓2.0%	-233↑13.0%	-161↑30.9%
Net Income	128	-280↓319.3%	-263↑6.0%	-227↑13.8%	-194↑14.6%
EBITDA	170	-244↓244.1%	-239↑2.0%	-198↑17.2%	-146↑26.6%
EPS Diluted	2.91	-6.50↓323.4%	-6.02↑7.4%	-4.59↑23.8%	-3.76↑18.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	345	97↓71.9%	35↓64.4%	58↑66.6%	34↓40.1%
Total Current Assets	519	416↓19.8%	335↓19.5%	278↓17.0%	281↑1.2%
Total Assets	1,114	833↓25.2%	574↓31.1%	466↓18.8%	453↓2.8%
Total Current Liabilities	130	130↓0.0%	130↓0.1%	103↓20.8%	118↑14.4%
Total Liabilities	350	317↓9.3%	262↓17.3%	206↓21.3%	350↑69.8%
Total Equity	764	516↓32.5%	312↓39.6%	260↓16.7%	103↓60.4%
Total Debt	87	95↑9.4%	89↓5.8%	82↓8.1%	261↑217.6%
Net Debt	-259	-2↑99.2%	55↑2643.8%	25↓55.3%	226↑822.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	219	-207↓194.8%	-218↓5.3%	-173↑20.7%	-124↑28.4%
Capital Expenditure	-84	-31↑63.5%	-10↑67.6%	-2↑75.5%	-2↑0.9%
Free Cash Flow	135	-238↓276.8%	-228↑4.1%	-176↑23.1%	-126↑28.0%
Stock-Based Comp	39	41↑5.1%	40↓1.3%	38↓4.5%	35↓10.1%
Net Change in Cash	7	-248↓3417.6%	-62↑74.9%	23↑136.8%	-23↓200.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance